CannPal Animal Therapeutics Limited (ASX:CP1)

Healthcare

CannPal Animal Therapeutics Limited (ASX: CP1) – It is a health care company and in the first quarter of this year it planned to begin its pharmacokinetic and safety clinical trials using its CPAT-01 drug.

Similar Companies

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK